Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 2, 2009, Pages 348-355

  Hawkins, Vivian N ^a   Suzuki, Stephanie M ^a   Rungsihirunrat, Kanchana ^b,c   Hapuarachchi, Hapuarachchige C ^d   Maestre, Amanda ^e   Na Bangchang, Kesara ^c   Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

^d UNIVERSITY OF KELANIYA   (Sri Lanka)

^e UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHLOROQUINE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; PHOSPHOTRANSFERASE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONVERGENT EVOLUTION; DHPS GENE; DNA FLANKING REGION; EXON; GENE; GENE AMPLIFICATION; GENE MUTATION; HAPLOTYPE; HUMAN; INTRON; MUTANT; NATURAL POPULATION; NONHUMAN; PARASITE ISOLATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PPPK GENE; WILD TYPE;

PLASMODIUM VIVAX;

EID: 68549115282     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.81.348     Document Type: Article

References (35)

1. Findlay GM, 1951. Sulphonamides and sulphones. Findlay GM, ed. Recent Advances in Chemotherapy, 3rd edition. London: J & A Churchill, Ltd., 377-403.
2. Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH, 2007. Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol 23: 213-222. (Pubitemid 46621225)
3. Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkenberg E, Whitty CJ, Rowland M, 2007. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. JAMA 297: 2201-2209. (Pubitemid 47010877)
4. Gregson A, Plowe CV, 2005. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 57: 117-145. (Pubitemid 40283971)
5. Hyde JE, 2005. Exploring the folate pathway in Plasmodium falciparum. Acta Trop 94: 191-206.
6. Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM, 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 17: 582-588.
7. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153. (Pubitemid 24226820)
8. Triglia T, Menting JG, Wilson C, Cowman AF, 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94: 13944-13949. (Pubitemid 28009689)
9. Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, Dao LD, Mshinda H, Tanner M, Watkins WM, Sims PF, Hyde JE, 1997. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 89: 161-177. (Pubitemid 27435090)
10. Korsinczky M, Fischer K, Chen N, Baker J, Rieckmann K, Cheng Q, 2004. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob Agents Chemother 45: 2214-2222. (Pubitemid 38691621)
11. Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q, 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg 75: 617-621. (Pubitemid 46941264)
12. Imwong M, Pukrittayakamee S, Cheng Q, Moore C, Looareesuwan S, Snounou G, White NJ, Day NP, 2005. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob Agents Chemother 49: 4393-4395. (Pubitemid 41400997)
13. Menegon M, Majori G, Severini C, 2006. Genetic variations of the Plasmodium vivax dihydropteroate synthase gene. Acta Trop 98: 196-199. (Pubitemid 43783138)
14. Rungsihirunrat K, Na-Bangchang K, Hawkins VN, Mungthin M, Sibley CH, 2007. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand. Am J Trop Med Hyg 76: 1057-1065. (Pubitemid 351837866)
15. Rungsihirunrat K, Sibley CH, Mungthin M, Na-Bangchang K, 2008. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand. Am J Trop Med Hyg 78: 462-467. (Pubitemid 351845198)
16. Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M, 2007. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka. Malar J 6: 28. (Pubitemid 46474681)
17. Anderson TJ, Roper C, 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop 94: 269-280. (Pubitemid 40720332)
18. Cortese JF, Caraballo A, Contreras CE, Plowe CV, 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186: 999-1006.
19. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA, 2007. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother 51: 2085-2091. (Pubitemid 46903098)
20. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B, 2003. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361: 1174-1181. (Pubitemid 36398386)
21. Pearce RJ, Pota H, Evehe MS, Ba el H, Mombo-Ngoma G, Malisa AL, Ord R, Inojosa W, Matondo A, Diallo DA, Mbacham W, van den Broek IV, Swarthout TD, Getachew A, Dejene S, Grobusch MP, Njie F, Dunyo S, Kweku M, Owusu-Agyei S, Chandramohan D, Bonnet M, Guthmann JP, Clarke S, Barnes KI, Streat E, Katokele ST, Uusiku P, Agboghoroma CO, Elegba OY, Cisse B, A-Elbasit IE, Giha HA, Kachur SP, Lynch C, Rwakimari JB, Chanda P, Hawela M, Sharp B, Naidoo I, Roper C, 2009. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med 6: e1000055.
22. Collins WE, Warren M, Huong AY, Skinner JC, Sutton BB, Stanfill PS, 1986. Studies of comparative infectivity of fifteen strains of Plasmodium vivax to laboratory-reared anopheline mosquitoes, with special reference to Anopheles culicifacies. J Parasitol 72: 521-524.
23. Young MD, Porter JA Jr, Johnson CM, 1966. Plasmodium vivax transmitted from man to monkey to man. Science 153: 1006-1007.
24. Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH, 2008. Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase. Malar J 7: 72. (Pubitemid 351679529)
25. Hastings MD, Porter KM, Maguire JD, Susanti I, Kania W, Bangs MJ, Sibley CH, Baird JK, 2004. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J Infect Dis 189: 744-750. (Pubitemid 38270930)
26. Bandelt HJ, Forster P, Rohl A, 1999. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16: 37-48. (Pubitemid 29024937)
27. Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, White NJ, Nosten F, Anderson TJ, 2003. A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites. Mol Biol Evol 20: 1526-1536. (Pubitemid 37082588)
28. McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YP, Ouma P, Vulule J, Bloland P, Slutsker L, Barnwell JW, Udhayakumar V, Escalante AA, 2006. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis 194: 189-197. (Pubitemid 44087190)
29. Pearce R, Malisa A, Kachur SP, Barnes K, Sharp B, Roper C, 2005. Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol Biol Evol 22: 1834-1844. (Pubitemid 41191510)
30. Ndiaye D, Daily JP, Sarr O, Ndir O, Gaye O, Mboup S, Roper C, Wirth DF, 2006. Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal. Acta Trop 99: 106-111. (Pubitemid 44402244)
31. Nash D, Nair S, Mayxay M, Newton PN, Guthmann JP, Nosten F, Anderson TJ, 2005. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc Biol Sci 272: 1153-1161. (Pubitemid 41020275)
32. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T, 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124.
33. Triglia T, Cowman AF, 1999. The mechanism of resistance to sulfa drugs in Plasmodium falciparum. Drug Resist Updat 2: 15-19. (Pubitemid 29217090)
34. Wang P, Read M, Sims PF, Hyde JE, 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 23: 979-986. (Pubitemid 27096733)
35. Baird JK, 2004. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48: 4075-4083.